Innocoll is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical technologies to meet some of today’s most important healthcare challenges. Our current late-stage product pipeline is focused on addressing patient needs for postsurgical pain management.
Postsurgical Pain Management Product Currently in Development
XARACOLL® is a novel collagen-matrix implant in late-stage development designed to deliver bupivacaine HCl to the surgical site.